OH Pharma
Products › Growth hormone axis › Tesamorelin 10 mg
Tesamorelin 10 mg OH PharmaTesamorelin 10 mg OH Pharma – back of vial
Tesamorelin 20 mg OH PharmaTesamorelin 20 mg OH Pharma – back of vial

Swipe to see the other strengths

Growth hormone axis · File 13

Tesamorelin 10 mg

Certificate of analysis available

✓Sterility and endotoxins tested by Nelson Labs (Salt Lake City)

Purity (HPLC)99.5 %
LotGN2605
LaboratoryBTLabs
Calculate a dose →

Description

Synthetic GHRH analogue that stimulates the pituitary's natural production of growth hormone.

Studied benefits

  • Reduced abdominal visceral fat in adults living with HIV who have lipodystrophy.
  • Improved perception of abdominal appearance in this population.
  • Reduced liver fat in trials of people living with HIV who have steatosis.
  • Stimulation of GH secretion and increase in IGF-1.

Results reported in published research; they guarantee no effect and are not an indication for use.

🔬 What the research says
  • In the phase 3 trials that led to its approval, tesamorelin reduced abdominal visceral fat compared with placebo in adults living with HIV.
⚠️ Warnings and reported side effects
  • Injection-site reactions, joint and muscle pain, swelling of the extremities.
  • Possible rise in blood sugar; hypersensitivity reactions reported.
  • Contraindicated during pregnancy, with active cancer or with pituitary disorders.

Consult a healthcare professional before any use. If an adverse effect occurs, stop use and see a doctor.

Certificate details

Laboratory
BTLabs (West Palm Beach, FL, United States)
Report number
IF-824-QSA-TR006-BTL26632-10
Substance analyzed
Tesamorelin
Lot
GN2605
Analysis date
June 1, 2026
Report date
June 5, 2026
Labelled sample content
10 mg
Sample ID
005000040271702

Results

TestMethodSpecificationResult
Identity and composition (FTIR)USP <197A>Confirms the presence of the peptideConfirmedPass
Purity (HPLC)USP <621>≥ 98 %99.5 %Pass
Measured content (HPLC)USP <621>90 – 110 % de 10 mg11.2 mg (112 %)Out of specification
Total massUSP <41>As measured97.1 mg

According to the laboratory, this analysis covers identity, purity, content and composition. It does not cover particulates, microbial contamination or endotoxins. Sterility and endotoxins are tested separately by Nelson Labs (Salt Lake City, Utah).

How to read this certificate →

Original certificate

Certificate of analysis Tesamorelin 10 mg, page 1Certificate of analysis Tesamorelin 10 mg, page 2 Download the certificate (PDF)

Sources

  1. Health Canada approves Egrifta (2014)
  2. CATIE — Tesamorelin

For educational purposes only. This information summarizes published studies and is neither a recommendation for use nor medical advice.

← Back to products